$ELTP called 9/21/13 $0.16 a 5-bagger now.
Post# of 63696
Posted On: 03/05/2014 7:57:46 AM
$ELTP called 9/21/13
$0.16
a 5-bagger now.
Shares Outstanding 527,082,097 a/o Feb 05, 2014
Float Not Available
03/05/14
7:30 AM EST Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study
for Abuse Deterrent Product ELI-200 - GlobeNewswire
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
2/18/2014 7:00:00 AM - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014
2/14/2014 9:49:00 AM - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014
2/10/2014 3:26:00 PM - GlobeNewswire
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product
1/14/2014 1:21:00 PM - GlobeNewswire
Elite Pharmaceuticals: Swinging For The Fences
12/18/2013 10:53:00 AM - Seeking Alpha
$0.16
a 5-bagger now.
Shares Outstanding 527,082,097 a/o Feb 05, 2014
Float Not Available
03/05/14
7:30 AM EST Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study
for Abuse Deterrent Product ELI-200 - GlobeNewswire
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
2/18/2014 7:00:00 AM - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014
2/14/2014 9:49:00 AM - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014
2/10/2014 3:26:00 PM - GlobeNewswire
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product
1/14/2014 1:21:00 PM - GlobeNewswire
Elite Pharmaceuticals: Swinging For The Fences
12/18/2013 10:53:00 AM - Seeking Alpha
(0)
(0)Scroll down for more posts ▼